Skip to Content
Merck
CN
  • PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.

PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.

Blood (2017-02-06)
Takeru Asano, Yusuke Meguri, Takanori Yoshioka, Yuriko Kishi, Miki Iwamoto, Makoto Nakamura, Yasuhisa Sando, Hideo Yagita, John Koreth, Haesook T Kim, Edwin P Alyea, Philippe Armand, Corey S Cutler, Vincent T Ho, Joseph H Antin, Robert J Soiffer, Yoshinobu Maeda, Mitsune Tanimoto, Jerome Ritz, Ken-Ichi Matsuoka
ABSTRACT

CD4